These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 36719486)

  • 21. A Perspective on Quantitative Systems Pharmacology Applications to Clinical Drug Development.
    Bai JPF; Earp JC; Strauss DG; Zhu H
    CPT Pharmacometrics Syst Pharmacol; 2020 Dec; 9(12):675-677. PubMed ID: 33159491
    [No Abstract]   [Full Text] [Related]  

  • 22. Innovative approaches in CNS clinical drug development: Quantitative systems pharmacology.
    Lacroix C; Soeiro T; Le Marois M; Guilhaumou R; Cassé-Perrot C; Jouve E; Röhl C; Belzeaux R; Micallef J; Blin O
    Therapie; 2021; 76(2):111-119. PubMed ID: 33358366
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Artificial Intelligence and Pharmacometrics: Time to Embrace, Capitalize, and Advance?
    Chaturvedula A; Calad-Thomson S; Liu C; Sale M; Gattu N; Goyal N
    CPT Pharmacometrics Syst Pharmacol; 2019 Jul; 8(7):440-443. PubMed ID: 31006175
    [No Abstract]   [Full Text] [Related]  

  • 24. Biostatistics and pharmacometrics: quantitative sciences to propel drug development forward.
    Smith BP; Vincent J
    Clin Pharmacol Ther; 2010 Aug; 88(2):141-4. PubMed ID: 20648027
    [No Abstract]   [Full Text] [Related]  

  • 25. Development of and insights from systems pharmacology models of antibody-drug conjugates.
    Lam I; Pilla Reddy V; Ball K; Arends RH; Mac Gabhann F
    CPT Pharmacometrics Syst Pharmacol; 2022 Aug; 11(8):967-990. PubMed ID: 35712824
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Towards Quantitative Systems Pharmacology Models of Chemotherapy-Induced Neutropenia.
    Craig M
    CPT Pharmacometrics Syst Pharmacol; 2017 May; 6(5):293-304. PubMed ID: 28418603
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Introduction of quantitative methods in pharmacology and clinical pharmacology: a historical overview.
    Atkinson AJ; Lalonde RL
    Clin Pharmacol Ther; 2007 Jul; 82(1):3-6. PubMed ID: 17571065
    [No Abstract]   [Full Text] [Related]  

  • 28. Where Do PBPK Models Stand in Pharmacometrics and Systems Pharmacology?
    Jamei M
    CPT Pharmacometrics Syst Pharmacol; 2020 Feb; 9(2):75-76. PubMed ID: 31905421
    [No Abstract]   [Full Text] [Related]  

  • 29. A Quantitative Systems Pharmacology Perspective on the Importance of Parameter Identifiability.
    Sher A; Niederer SA; Mirams GR; Kirpichnikova A; Allen R; Pathmanathan P; Gavaghan DJ; van der Graaf PH; Noble D
    Bull Math Biol; 2022 Feb; 84(3):39. PubMed ID: 35132487
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacometrics and the transition to model-based development.
    Grasela TH; Dement CW; Kolterman OG; Fineman MS; Grasela DM; Honig P; Antal EJ; Bjornsson TD; Loh E
    Clin Pharmacol Ther; 2007 Aug; 82(2):137-42. PubMed ID: 17632539
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Model-informed target identification and validation through combining quantitative systems pharmacology with network-based analysis.
    Chelliah V; van der Graaf PH
    CPT Pharmacometrics Syst Pharmacol; 2022 Apr; 11(4):399-402. PubMed ID: 35178891
    [No Abstract]   [Full Text] [Related]  

  • 32. A Flexible Approach for Context-Dependent Assessment of Quantitative Systems Pharmacology Models.
    Ramanujan S; Chan JR; Friedrich CM; Thalhauser CJ
    CPT Pharmacometrics Syst Pharmacol; 2019 Jun; 8(6):340-343. PubMed ID: 30983158
    [No Abstract]   [Full Text] [Related]  

  • 33. Incorporating Placebo Response in Quantitative Systems Pharmacology Models.
    Wang EB; Shen L; Heathman M; Chan JR
    CPT Pharmacometrics Syst Pharmacol; 2019 Jun; 8(6):344-346. PubMed ID: 30983120
    [No Abstract]   [Full Text] [Related]  

  • 34. Pharmacometrics and systems biology in oncology: is there an intersection?
    Kloft C
    Int J Clin Pharmacol Ther; 2013 Jan; 51(1):89-90. PubMed ID: 23260011
    [No Abstract]   [Full Text] [Related]  

  • 35. Systems pharmacology - Towards the modeling of network interactions.
    Danhof M
    Eur J Pharm Sci; 2016 Oct; 94():4-14. PubMed ID: 27131606
    [TBL] [Abstract][Full Text] [Related]  

  • 36. ASCPT Task Force for advancing pharmacometrics and integration into drug development.
    Goldberger MJ; Singh N; Allerheiligen S; Gobburu JV; Lalonde R; Smith B; Ryder S; Yozviak A
    Clin Pharmacol Ther; 2010 Aug; 88(2):158-61. PubMed ID: 20648032
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical Pharmacology and Pharmacometrics to Better Understand Physiological Changes During Pregnancy and Neonatal Life.
    van Donge T; Evers K; Koch G; van den Anker J; Pfister M
    Handb Exp Pharmacol; 2020; 261():325-337. PubMed ID: 30968215
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Recent applications of quantitative systems pharmacology and machine learning models across diseases.
    Aghamiri SS; Amin R; Helikar T
    J Pharmacokinet Pharmacodyn; 2022 Feb; 49(1):19-37. PubMed ID: 34671863
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Welcome to the statistics and pharmacometrics themed issue.
    French J; Mentré F
    CPT Pharmacometrics Syst Pharmacol; 2021 Apr; 10(4):273-274. PubMed ID: 33951754
    [No Abstract]   [Full Text] [Related]  

  • 40. Quantitative system pharmacology as a legitimate approach to examine extrapolation strategies used to support pediatric drug development.
    Azer K; Barrett JS
    CPT Pharmacometrics Syst Pharmacol; 2022 Jul; 11(7):797-804. PubMed ID: 35411657
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.